Mucosal healing with infliximab: Results from the active ulcerative colitis trials

Gastroenterology and Hepatology

Volumn 8, Issue 2, 2012, Pages 117-119

  Sandborn, William J ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; C REACTIVE PROTEIN; CERTOLIZUMAB PEGOL; INFLIXIMAB; PLACEBO; STEROID;

COLON MUCOSA; COLON RESECTION; DRUG EFFICACY; HUMAN; NOTE; TREATMENT OUTCOME; ULCER HEALING; ULCERATIVE COLITIS;

EID: 84856822196     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (5)

1. Colombel JF, Rutgeerts P, Reinisch W, et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology. 2011;141:1194-1201.
2. Sandborn WJ, Rutgeerts P, Feagan BG, et al. Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab. Gastroenterology. 2009;137:1250-1260; quiz 1520.
3. Lichtenstein GR, Rutgeerts P. Importance of mucosal healing in ulcerative colitis. Inflamm Bowel Dis. 2010;16:338-346.
4. Fiorino G, Cesarini M, Indriolo A, Malesci A. Mucosal healing in ulcerative colitis: where do we stand? Curr Drug Targets. 2011;12:1417-1423.
5. Fratila OC, Craciun C. Ultrastructural evidence of mucosal healing after infliximab in patients with ulcerative colitis. J Gastrointestin Liver Dis. 2010;19:147-153.